Prescribed antibiotic use in Australian children aged 0-12 years

Svetla Gadzhanova1, Elizabeth Roughead

  • 1PhD, is Research Fellow, Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, The University of South Australia.

Insights

Nearly half of Australian children aged 0-12 years were prescribed systemic antibiotics in 2013. This high antibiotic use in pediatric populations highlights the need for education on appropriate antibiotic stewardship.

Area of Science:

  • Pediatric Pharmacology
  • Public Health
  • Infectious Disease Epidemiology

Background:

  • Antibiotic prescribing is common in children, but usage patterns are not well understood.
  • Limited data exists on the national scope of pediatric antibiotic utilization.

Purpose of the Study:

  • To investigate current medicine use in Australian children.
  • To specifically analyze antibiotic prescribing trends in pediatric populations using national data.

Main Methods:

  • A longitudinal study design was employed.
  • Utilized a 10% random sample of Australian Pharmaceutical Benefits Scheme (PBS) data from 2013.
  • Included children aged 0-12 years who received at least one medicine dispensing.

Main Results:

  • In 2013, 49% of 0-4 year olds, 44% of 5-9 year olds, and 33% of 10-12 year olds received systemic antibiotics.
  • Over half (53%) of children had single antibiotic dispensings.
  • The majority (71%) of children had no comorbid conditions, and antibiotics were often dispensed alone.

Conclusions:

  • The study reveals a high prevalence of antibiotic use among Australian children.
  • Findings underscore the critical need for educating children and parents on appropriate antibiotic indications and stewardship.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Antibiotic Selection00:57

Antibiotic Selection

Overview
62.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
713
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
10
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
44